haloperidol has been researched along with Antiphospholipid Syndrome in 3 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Antiphospholipid Syndrome: The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here, we report a typical case of 'senile chorea' associated with PAPS, thus expanding the potential underlying etiologies and further narrowing the window of primary 'senile chorea'." | 1.35 | Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome. ( Apale, P; Appollonio, I; Capra, M; Ferrarese, C; Frigo, M; Galbussera, A; Gelosa, G; Perego, R; Tremolizzo, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brogna, C | 1 |
| Mariotti, P | 1 |
| Manna, R | 1 |
| Gelosa, G | 1 |
| Tremolizzo, L | 1 |
| Galbussera, A | 1 |
| Perego, R | 1 |
| Capra, M | 1 |
| Frigo, M | 1 |
| Apale, P | 1 |
| Ferrarese, C | 1 |
| Appollonio, I | 1 |
| Toren, P | 1 |
| Toren, A | 1 |
| Weizman, A | 1 |
| Mozes, T | 1 |
| Eldar, S | 1 |
| Magor, A | 1 |
| Mandel, M | 1 |
| Rechavi, G | 1 |
| Many, A | 1 |
| Mester, R | 1 |
3 other studies available for haloperidol and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea.
Topics: Antiphospholipid Syndrome; Child; Chorea; Dopamine Antagonists; Haloperidol; Humans; Immunoglobulins | 2014 |
Narrowing the window for 'senile chorea': a case with primary antiphospholipid syndrome.
Topics: Age of Onset; Aged; Anti-Dyskinesia Agents; Antibodies, Antiphospholipid; Anticonvulsants; Antiphosp | 2009 |
Tourette's disorder: is there an association with the antiphospholipid syndrome?
Topics: Adolescent; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Child; Haloperidol; Humans; Imm | 1994 |